Clinical Study
Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
Table 4
Fasting and postprandial profiles of the measured parameters in patients receiving exenatide and liraglutide on visit 2.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are means ± SD. indicates the result of ANOVA for repeated measurements within each group ( value for the effect of time); indicates the result of ANOVA for repeated measurements between the two groups (exenatide versus liraglutide) (time × group interaction). |